9960 Stock Overview
An investment holding company, provides clinical testing services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Kindstar Globalgene Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.10 |
| 52 Week High | HK$1.79 |
| 52 Week Low | HK$0.93 |
| Beta | 0.72 |
| 1 Month Change | -5.98% |
| 3 Month Change | -9.84% |
| 1 Year Change | -32.93% |
| 3 Year Change | -80.11% |
| 5 Year Change | n/a |
| Change since IPO | -87.83% |
Recent News & Updates
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings
Oct 04
Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story
Oct 03Recent updates
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings
Oct 04Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story
Oct 03We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings
Apr 03Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Aug 22Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts
Aug 18We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate
Jul 07Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 28Shareholder Returns
| 9960 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -3.5% | -1.3% | -0.5% |
| 1Y | -32.9% | -17.8% | 19.9% |
Return vs Industry: 9960 underperformed the Hong Kong Healthcare industry which returned -17.8% over the past year.
Return vs Market: 9960 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 9960 volatility | |
|---|---|
| 9960 Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 9960 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 9960's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 3,193 | Shiang Huang | www.kindstar.com.cn/en/ |
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases.
Kindstar Globalgene Technology, Inc. Fundamentals Summary
| 9960 fundamental statistics | |
|---|---|
| Market cap | HK$1.07b |
| Earnings (TTM) | HK$9.80m |
| Revenue (TTM) | HK$1.01b |
109.3x
P/E Ratio1.1x
P/S RatioIs 9960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9960 income statement (TTM) | |
|---|---|
| Revenue | CN¥947.84m |
| Cost of Revenue | CN¥513.76m |
| Gross Profit | CN¥434.08m |
| Other Expenses | CN¥424.88m |
| Earnings | CN¥9.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0094 |
| Gross Margin | 45.80% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | 10.8% |
How did 9960 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield268%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:52 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kindstar Globalgene Technology, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yang Huang | Credit Suisse |
| Tianyi Yan | Goldman Sachs |
| Jiaqi Zhu | Zhongtai Securities Co. Ltd. |